Table 2. Univariate and multivariate Cox proportional hazard analysis for MCC related death, death from any cause et MCC recurrence.
Covariate | Cancer Specific survival | Overall survival | MCC Recurrence (any site) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Univariate
analysis |
Multivariate
analysis |
Univariate
analysis |
Multivariate
analysis |
Univariate
analysis |
Multivariate
analysis |
|||||||
HR (95% CI) | p | HR (95% CI) | p | HR (95% CI) | p | aHR (95% CI) | p | HR (95% CI) | p | aHR (95% CI) | p | |
Age (years) | ||||||||||||
>80.5 vs. ≤80.5 | 2.86 (1.08–7.54) | 0.034 | 4.85 (1.39–16.9) | 0.013 | 2.85 (1.37–5.95) | 0.005 | 3.85 (1.56–9.48) | 0.003 | 1.13 (0.50–2.56) | 0.772 | 0.75 (0.26–2.16) | 0.590 |
Sex | ||||||||||||
male vs. female | 1.99 (0.81–4.92) | 0.135 | 4.64 (1.31–16.41) | 0.017 | 1.43 (0.71–2.88) | 0.321 | 2.75 (1.10–6.84) | 0.030 | 1.94 (0.85–4.42) | 0.113 | 1.56 (0.57–4.28) | 0.389 |
AJCC | ||||||||||||
3–4 vs. 1–2 | 1.82 (0.73–4.55) | 0.196 | 2.16 (0.73–6.35) | 0.161 | 0.90 (0.42–1.96) | 0.800 | 1.65 (0.68–3.98) | 0.265 | 1.41 (0.60–3.34) | 0.431 | 1.64 (0.63–4.28) | 0.314 |
Immunosuppression | ||||||||||||
present vs. absent | 1.85 (0.54–6.41) | 0.327 | 3.29 (0.79–13.71) | 0.101 | 3.23 (1.28–8.14) | 0.013 | 5.25 (1.82–15.2) | 0.002 | 1.39 (0.41–4.70) | 0.593 | 2.24 (0.60–8.34) | 0.230 |
MCPyV status | ||||||||||||
positive vs. negative | 0.26 (0.00–0.67) | 0.005 | 0.42 (0.16–1.09) | 0.076 | 0.29 (0.00–0.61) | 0.001 | 0.37 (0.00–0.83) | 0.017 | 0.23 (0.00–0.55) | 0.001 | 0.20 (0.00–0.57) | 0.002 |
GPC3 expression | ||||||||||||
positive vs. negative | 2.24 (0.74–6.75) | 0.153 | 4.05 (1.06–15.43) | 0.040 | 1.58 (0.72–3.46) | 0.252 | 2.42 (0.89–6.54) | 0.082 | 1.45 (0.60–3.53) | 0.412 | 1.34 (0.48–3.79) | 0.576 |
Abbreviations: HR: Hazard Ratio; aHR: adjusted HR; CI: confidence interval; MCC: Merkel Cell Carcinoma.